INFERTILITY l Assessment and treatment of patients with

  • Slides: 54
Download presentation
INFERTILITY l Assessment and treatment of patients with fertility problems Dr Nitu Raje-Ghatge

INFERTILITY l Assessment and treatment of patients with fertility problems Dr Nitu Raje-Ghatge

Why learn about it? Its in the curriculum ! l l l Infertility –

Why learn about it? Its in the curriculum ! l l l Infertility – primary/ secondary Investigations eg hormone tests Knowledge of subfertility secondary care investigations Primary care management Knowledge of specialist treatments and surgical procedures

Why learn about it. . Expectations from secondary care services! l Inappropriate timing of

Why learn about it. . Expectations from secondary care services! l Inappropriate timing of referrals (early/late) l Incomplete /inadequate investigations

What is infertility? l NICE: Failure to conceive after regular UPSI for 2 years

What is infertility? l NICE: Failure to conceive after regular UPSI for 2 years in the absence of reproductive pathology. P. S NICE suggests offer clinical investigations if failure to conceive after 1 year of UPSI. l GP NOTEBOOK: Infertility is the failure of conception in a couple having regular, unprotected coitus for 1 year, provided that normal intercourse is occurring not less than twice weekly.

Natural conception rates: l l l 80% of couples will be pregnant after 12

Natural conception rates: l l l 80% of couples will be pregnant after 12 cycles. 50% of remaining will conceive during a 2 nd year ( hence cumulative rate 90%) 50% in the following 4 years.

PRIMARY/SECONDARY INFERTILITY l PRIMARY – Couple without a prior pregnancy l SECONDARY – Couple

PRIMARY/SECONDARY INFERTILITY l PRIMARY – Couple without a prior pregnancy l SECONDARY – Couple with previous pregnancy including miscarriage/ectopic.

Etiology: l l Male factors Female factors Unexplained -20% Mixed – 15%

Etiology: l l Male factors Female factors Unexplained -20% Mixed – 15%

Male Account for 25% l Hypogonadotrophic hypogonadism l Obstructive azoospermia Surgery l Erectile dysfunction

Male Account for 25% l Hypogonadotrophic hypogonadism l Obstructive azoospermia Surgery l Erectile dysfunction l Anatomical - Hypospadias - Undescended/ maldescended testis

Female l Peritoneal factors 40%, - Endometriosis. l Tubal blockage 20%.

Female l Peritoneal factors 40%, - Endometriosis. l Tubal blockage 20%.

Etiology (female) l l l Ovulatory dysfunction 15 -20% - Hypothalamic/hypogonadotrophic hypogonadism - Hypothalamic

Etiology (female) l l l Ovulatory dysfunction 15 -20% - Hypothalamic/hypogonadotrophic hypogonadism - Hypothalamic pituitary dysfunction (PCOS) - Ovarian failure Uterine cavity abnormalities - Asherman's syndrome - Uterine fibroids. Cervical hostility 5 -10%, - Infection - Female sperm antibodies.

l Fertility may be impaired in poorly controlled diabetes.

l Fertility may be impaired in poorly controlled diabetes.

History taking (female) l Symptoms (past or present) - P I D / STD,

History taking (female) l Symptoms (past or present) - P I D / STD, - dysparenuria - galactorrhoea, - thyroid symptoms l Obstetric history

History taking (female) Menstrual history - irregularities l Surgical history – D & C,

History taking (female) Menstrual history - irregularities l Surgical history – D & C, abdominal/pelvic surgery l Contraception l - IUCDs l Cervical smear

History taking (male) l Symptoms h/o genital tract infection e. g. mumps orchitis, prostatitis

History taking (male) l Symptoms h/o genital tract infection e. g. mumps orchitis, prostatitis l Surgical history - Hernia repair - Testicular surgery for torsion/ undescended /maldescended testis - Prostate surgery

History taking (male) l Trauma to the male genital or inguinal region l Occupational

History taking (male) l Trauma to the male genital or inguinal region l Occupational history - exposure to lead, cadmium l Drug history - Sulphasalazine – impairs spermatogenesis - Phenothiazines/ typical antipsychotics/ metoclopramide increase prolactin levels - Immunosuppresants

IN BOTH l l l Smoking Alcohol intake Psychological factors

IN BOTH l l l Smoking Alcohol intake Psychological factors

EXAMINATION General health and nutritional status l BMI <19 (F) > 29. (M/F) l

EXAMINATION General health and nutritional status l BMI <19 (F) > 29. (M/F) l SSC l

Female: Hirsuitism, galactorrhoea l Bimanual examination - adnexal masses (tubo/ovarian, ovarian cyst) l -

Female: Hirsuitism, galactorrhoea l Bimanual examination - adnexal masses (tubo/ovarian, ovarian cyst) l - tenderness (PID/ endometriosis) - Uterine fibroids

Male l l l Hypospadias Size and consistency of each testicle and epididymis; Presence

Male l l l Hypospadias Size and consistency of each testicle and epididymis; Presence of varicocele or hernia; Size of prostate. Gynaecomastia

Now what? ? Investigate Or Refer

Now what? ? Investigate Or Refer

Early referral if. . l l Female Age >35 years Amenorrhoea/ oligo menorrhoea PID

Early referral if. . l l Female Age >35 years Amenorrhoea/ oligo menorrhoea PID Abnormal pelvic exam l l l Male Undescended testes Previous genital pathology Previous urogenital surgery In Both Prior treatment for cancer HIV, Hep B, Hep C

Investigations Primary care Female Assess ovulation. Other hormonal tests Tests for PID Male Sperm

Investigations Primary care Female Assess ovulation. Other hormonal tests Tests for PID Male Sperm analysis Secondary care Tubal patency Uterine abnormality

Assessing ovulation Do if l regular cycles with > 1 year of infertility l

Assessing ovulation Do if l regular cycles with > 1 year of infertility l irregular cycles 1) Serum progesterone 2) LH/FSH levels

INVESTIGATIONS (Female) 1) Serum progesterone (mid luteal phase ie day 21 of 28 week

INVESTIGATIONS (Female) 1) Serum progesterone (mid luteal phase ie day 21 of 28 week cycle) Timing is important!!! l l Regular cycles - 7 days before next MP Irregular cycles - day 28/35 wk then weekly till menstruation occurs

Interpretation of test Interpret after next LMP known <16 nmol/l Repeat in another cycle.

Interpretation of test Interpret after next LMP known <16 nmol/l Repeat in another cycle. Refer if consistently low >16 nmol/l but <30 nmol/l Repeat in another cycle. Refer if same/lower >30 nmol/l Consider as proof of adequate ovula

Assessing ovulation 2) LH/FSH levels High levels – poor ovarian function High LH compared

Assessing ovulation 2) LH/FSH levels High levels – poor ovarian function High LH compared to FSH -PCOS

Other hormonal tests l E 2, Testosterone levels – PCOS l Prolactin ONLY if

Other hormonal tests l E 2, Testosterone levels – PCOS l Prolactin ONLY if - ovulation problems - galactorrhoea, - pituitary problem.

Other hormonal tests l l Thyroid tests - only with symptoms/ signs Other androgen

Other hormonal tests l l Thyroid tests - only with symptoms/ signs Other androgen profile (DHEAS, Androstenedione, SBHG) – as per etiology

Tests for PID l l HVS Chlamydia screening

Tests for PID l l HVS Chlamydia screening

Don’t forget!! Rubella status - check immunity - Vaccinate if non immune, avoid conception

Don’t forget!! Rubella status - check immunity - Vaccinate if non immune, avoid conception for 3 months l

Cervical hostility Post coital test - no longer recommended by NICE l Mucus invasion

Cervical hostility Post coital test - no longer recommended by NICE l Mucus invasion test - doubtful significance l

Investigations (Male) Semen analysis l l Needs prior appointment with lab Abstinence for atleast

Investigations (Male) Semen analysis l l Needs prior appointment with lab Abstinence for atleast 3 days Transport to lab in 30 - 60 min Repeat abnormal test in next 3 months, earlier if gross abnormality

Semen analysis- interpretation (WHO values) l l l l Volume 2 mls or more

Semen analysis- interpretation (WHO values) l l l l Volume 2 mls or more Sperm concentration - 20 million/ml Sperm morphology - atleast 30% normal Sperm number - 40 million/ ejaculate Sperm motility – 50% Vitality – 75% WBC - <1 million/ml Anti sperm antibody tests- not recommended by NICE

Investigations in secondary care

Investigations in secondary care

Tests for uterine/tubal problems l l HSG/hystero salpingo-contrast USG Laparoscopy + dye test Done

Tests for uterine/tubal problems l l HSG/hystero salpingo-contrast USG Laparoscopy + dye test Done only when ovulation tests/Sperm tests normal. Choice of tests depends upon co morbidities

Management in primary care Principles of care l Couple centred management l Access to

Management in primary care Principles of care l Couple centred management l Access to evidence based information l Counselling (third person) l Contact with fertility support groups l Specialist teams

Positive approach Reassure about cumulative pregnancy rates

Positive approach Reassure about cumulative pregnancy rates

Management in primary care l Lifestyle changes - Weight reduction, BMI 19 -29 -

Management in primary care l Lifestyle changes - Weight reduction, BMI 19 -29 - Smoking cessation- offer support groups - Alcohol reduction <1 -2 units/week for women <3 -4 units/week for men - S I every 2 -3 days - Information about OTC/ recreational drugs

Management in primary care l Pre conceptual advice - Folic acid supplementation - Rubella

Management in primary care l Pre conceptual advice - Folic acid supplementation - Rubella status - Cervical screening l Management of erectile dysfunction - psychosexual couselling - drugs

Management in secondary care l Depends upon the etiology. .

Management in secondary care l Depends upon the etiology. .

Hypogonadotrophic hypogonadism l l l Pulsatile Gn. RH Gonadotrophins with LH activity Bromocriptine (

Hypogonadotrophic hypogonadism l l l Pulsatile Gn. RH Gonadotrophins with LH activity Bromocriptine ( for hyperprolactinaemia)

Ovarian dysfunction ( hypothalamic dysfunction) 1) Anti- oestrogens eg Clomiphene/ Tamoxifen - 1 st

Ovarian dysfunction ( hypothalamic dysfunction) 1) Anti- oestrogens eg Clomiphene/ Tamoxifen - 1 st line - use for atleast 12 months if ovulating initiated in secondary care under USG guidance ( to adjust dose) shared care when dose established S/E risk of multiple pregnancy, OHSS

Ovulatory dysfunction- treatment 2) Metformin - not licensed for ovulatory disorders in UK -

Ovulatory dysfunction- treatment 2) Metformin - not licensed for ovulatory disorders in UK - used 2 nd line with Clomiphene in - anovulatory women with PCOD + BMI >25 + no response to CC

Others… 3) Gonadotrophins 4) Luteal phase support – - progesterone, - clomiphene 5) Laparoscopic

Others… 3) Gonadotrophins 4) Luteal phase support – - progesterone, - clomiphene 5) Laparoscopic ovarian drilling

Peritoneal problems (endometriosis) l l Laparoscopic surgical ablation/ resection of endometriosis + adhesiolysis If

Peritoneal problems (endometriosis) l l Laparoscopic surgical ablation/ resection of endometriosis + adhesiolysis If ovarian endometriomas, laparoscopic cystectomy

Uterine/ tubal factors l Tubal factors: - Laparoscopic tubal surgery/ tubal microsurgery - Salpingography

Uterine/ tubal factors l Tubal factors: - Laparoscopic tubal surgery/ tubal microsurgery - Salpingography + tubal catheteristion - Hysteroscopic tubal cannulation l Uterine factors - hysteroscopic adhesiolysis - myomectomy

Assisted reproduction techniques l Intra uterine insemination (IUI)

Assisted reproduction techniques l Intra uterine insemination (IUI)

In vitrio fertilisation l l l Intracytoplasmic sperm injection (ICSI) Donor insemination Oocyte donation

In vitrio fertilisation l l l Intracytoplasmic sperm injection (ICSI) Donor insemination Oocyte donation

ACON at CRH l l Satellite IVF unit Counselling, monitoring and most of treatment

ACON at CRH l l Satellite IVF unit Counselling, monitoring and most of treatment , except egg retrieval and embryo transfer.

Central unit l l l Clarendon Wing, LGI SJUH, Leeds CARE, Manchester

Central unit l l l Clarendon Wing, LGI SJUH, Leeds CARE, Manchester

Questions…. . zzzz? ?

Questions…. . zzzz? ?